Vice President Erica VanSant to Join Panel on MFN Drug Pricing at the 13th Annual Summit for Women Leaders in Life Sciences Law
Event:Women Leaders in Life Sciences Law
Date:
July 30, 2026
Host:
American Conference Institute (ACI)
Location:
Boston, MA
Times:
8:00–8:45 a.m. (PT) / 11:00–11:45 a.m. (ET)
Analysis Group Vice President Erica VanSant will join a panel on Most Favored Nation (MFN) drug pricing at the 13th Annual Summit for Women Leaders in Life Sciences Law. The session, MFN Drug Pricing and the Future of Global Pharmaceutical Markets: Understanding the Implications for Pricing, Access, and Innovation, will examine the evolving MFN policy landscape and the ways legal and business leaders are evaluating its potential ripple effects across global markets. The discussion will address implications for pricing strategies, market entry and launch sequencing, and the US innovation pipeline.
Analysis Group is pleased to be an associate sponsor of the event.